LABTRACE.ORG BETA LIVE
221 source polls this hour 55 146 articles collected last article 9m ago 955 events on 2+ sources 0 embeddings/h feed queue 0 lag 356.4s
← all events
LT-028654 / first seen 2026-10-04 16:25 / last activity 1h ago

First Report from NRG-HN009 Randomized Phase II/III Trial of RT + Cisplatin Q3 Weeks vs RT + Cisplatin Weekly for Patients with Locoregionally Advanced SCCHN: p16+ Phase II Toxicity Results

measurement

heat
45 / 100 (raw 1.2)
velocity
0.0 independent sources per hour
solidity
80 / 100
sources
1 total, 1 independent
domain span
1 domain covered it

primary source

title
First Report from NRG-HN009 Randomized Phase II/III Trial of RT + Cisplatin Q3 Weeks vs RT + Cisplatin Weekly for Patients with Locoregionally Advanced SCCHN: p16+ Phase II Toxicity Results
venue
status
peer-reviewed
doi
10.1016/j.ijrobp.2026.02.048
published
2026-05-01

media coverage / 1 outlets